https://www.socictopen.socict.org/files/original/ef990904315351bee1c065c8823dad62.pdf 84d174cafbdd371591cb1f331bc39128 Dublin Core The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/. Title A name given to the resource Coronavirus Description An account of the resource Dominio científico: Coronavirus Text A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text. Dublin Core The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/. Title A name given to the resource Inhibitors of Angiotensin-converting Enzyme or Blockers of Angiotensin-2 Receptor in COVID-19 Patients with Comorbid Cardiovascular or Pulmonary Diseases Creator An entity primarily responsible for making the resource Amin Talebi Bezmin Abadi, Farid Rahimi Description An account of the resource Following the skyrocketing spread of SARS-CoV-2 into almost all the countries over five continents, diverse clinical strategies are urgently needed to defeat its pandemic, considering that an magic-bullet antiviral vaccine or treatment is presently unavailable. WHO later proclaimed the viral outbreak as a pandemic. Despite this fast speed of the pandemic, any recommended treatment must first pass initial clinical and para-clinical testing. Antiviral therapy, immunotherapy, and application of prophylactic vaccines are recommended in the management of this pandemic, but no definitive intervention has been validated to treat the COVID-19 patients. Whether SARS-CoV-2 infection can directly affect the cardiovascular system is unknown. Furthermore, other pathogenic mechanisms underlying this viral infection are largely unclear. Thus, it is risky to administer any intervention in emergency treatment of the vulnerable patients with comorbid CVDs. Conclusively, while we lack evidence-based facts to confirm a significant association between the poor prognosis of COVID-19 patients and high expression of angiotensin-converting enzyme 2, administering any new treatment in CVD patients should be done prudently. Date A point or period of time associated with an event in the lifecycle of the resource 2020 Subject The topic of the resource covid-19, Pandemic, SARS-CoV-2, cardiovascular disease, Gastrointestinal conditions, chronic pulmonary disease Source A related resource from which the described resource is derived Research in Molecular Medicine Publisher An entity responsible for making the resource available Mazandaran University of Medical Sciences and Health Services Coverage The spatial or temporal topic of the resource, the spatial applicability of the resource, or the jurisdiction under which the resource is relevant Medicine (General)